A Multi-Center, Randomized, Placebo-Controlled, Double-Blind, Adaptive Dose-Ranging Study to Assess Safety and Efficacy of Intravenous OCE-205 in Adults Diagnosed with Cirrhosis with Ascites who have Developed Hepatorenal Syndrome-Acute Kidney Injury
|Effective start/end date||3/21/22 → 3/31/27|
- OCELOT BIO, INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.